Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Taysha Gene Therapies Inc (NQ: TSHA ) 2.060 -0.180 (-8.04%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Taysha Gene Therapies Inc < Previous 1 2 3 4 5 6 7 8 9 Next > 12 Health Care Stocks Moving In Wednesday's Pre-Market Session October 26, 2022 Gainers Ensysce Biosciences (NASDAQ:ENSC) stock increased by 47.9% to $0.31 during Wednesday's pre-market session. The company's market cap stands at $11.8 million. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday October 26, 2022 It's time to start off the day with a breakdown of the biggest pre-market stock movers for Wednesday morning and the latest news! Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's After-Market Session October 25, 2022 Gainers DBV Technologies (NASDAQ:DBVT) stock increased by 18.7% to $1.9 during Tuesday's after-market session. The company's market cap stands at $356.7 million. Via Benzinga Nasdaq Surges Over 200 Points; General Electric Posts Downbeat Earnings October 25, 2022 U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday. Via Benzinga Stocks That Hit 52-Week Lows On Wednesday October 19, 2022 On Wednesday, 200 companies hit new 52-week lows. Via Benzinga Expert Ratings for Taysha Gene Therapies May 17, 2022 Within the last quarter, Taysha Gene Therapies (NASDAQ:TSHA) has observed the following analyst ratings: Via Benzinga Taysha Gene Therapies: Q1 Earnings Insights May 16, 2022 Taysha Gene Therapies (NASDAQ:TSHA) reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday October 26, 2022 Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session October 25, 2022 Gainers Via Benzinga Earnings Scheduled For May 16, 2022 May 16, 2022 Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday April 26, 2022 During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low. Via Benzinga Why Crown Holdings Shares Are Trading Lower By Around 22%? Here Are 46 Stocks Moving In Tuesday's Mid-Day Session October 25, 2022 Gainers Via Benzinga S&P 500 Rises Over 1%; General Motors Earnings Top Views October 25, 2022 U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1.8% on Tuesday. Via Benzinga Analyzing Taysha Gene Therapies's Short Interest October 25, 2022 Taysha Gene Therapies's (NASDAQ:TSHA) short percent of float has fallen 5.27% since its last report. The company recently reported that it has 889 thousand shares sold short, which is 4.31% of all... Via Benzinga Why Is Xerox (XRX) Stock Down 20% Today? October 25, 2022 Xerox (XRX) stock is heading lower on Tuesday thanks to the release of its earnings report for the third quarter of 2022. Via InvestorPlace Taysha Gene Therapies (NASDAQ: TSHA) Receives $50 Million Strategic Investment From Astellas Pharma to Develop AAV-Based Gene Therapeutics October 25, 2022 Taysha Gene Therapies, Inc. (NASDAQ: TSHA) is a biotechnology company that is focused on developing gene therapies to treat monogenic Via Spotlight Growth What Is Going on With Taysha Gene (TSHA) Stock Today? October 25, 2022 Taysha and its new partner Astellas are both speculating that Adeno Associated Viruses can create treatments for genetic diseases. Via InvestorPlace Astellas Pharma Invests $50M To Support Taysha's Gene Therapy Programs October 25, 2022 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session October 25, 2022 Gainers Taysha Gene Therapies (NASDAQ:TSHA) stock increased by 36.4% to $2.06 during Tuesday's pre-market session. The market value of their outstanding shares is at $84.6 million. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday October 25, 2022 We're starting off the day with an overview of the biggest pre-market stock movers on Tuesday and the latest news this morning! Via InvestorPlace Why Qualtrics International Shares Are Trading Sharply Higher; Here Are 23 Stocks Moving Premarket October 25, 2022 Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose 43% to $2.16 in pre-market trading. Astellas Pharma Inc. announced plans to invest a total of $50 million to acquire 15% of Taysha Gene... Via Benzinga What 4 Analyst Ratings Have To Say About Taysha Gene Therapies August 12, 2022 Taysha Gene Therapies (NASDAQ:TSHA) has observed the following analyst ratings within the last quarter: Via Benzinga Stocks That Hit 52-Week Lows On Wednesday May 25, 2022 On Wednesday, 215 companies set new 52-week lows. Via Benzinga Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday August 12, 2022 Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday May 24, 2022 On Tuesday, 540 companies set new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Monday May 16, 2022 On Monday, 198 companies reached new 52-week lows. Via Benzinga The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs May 03, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga What 6 Analyst Ratings Have To Say About Taysha Gene Therapies April 01, 2022 Analysts have provided the following ratings for Taysha Gene Therapies (NASDAQ:TSHA) within the last quarter: Via Benzinga 10 Biggest Price Target Changes For Friday April 01, 2022 Wells Fargo lowered the price target on General Motors Company (NYSE: GM) from $83 to $72. GM shares rose 0.8% to $44.10 in pre-market trading. Via Benzinga Stocks That Hit 52-Week Lows On Friday April 29, 2022 On Friday, 213 companies hit new 52-week lows. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.